Fig. 2From: Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancerCPN1 detection and clinical performance. A Comparative analysis of serum CPN1 expression in 34 cases; B, C CPN1 levels before and after chemotherapy in breast cancer patients with B post-chemotherapy efficacy PR (n = 10), C post-chemotherapy efficacy SD (n = 24) in breast cancer patient cases before and after chemotherapy. *Test X: the X observation pointBack to article page